Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.

Over the last decade, poxviral vectors emerged as a mainstay approach for the induction of T cell-mediated immunity by vaccination, and their suitability for human use has led to widespread clinical testing of candidate vectors against infectious intracellular pathogens and cancer. In contrast, poxv...

Полное описание

Библиографические подробности
Главные авторы:	Draper, S, Cottingham, MG, Gilbert, S
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.
по: de Cassan, S, и др.
Опубликовано: (2013)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
по: Alcock, R, и др.
Опубликовано: (2010)

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
по: Orubu, T, и др.
Опубликовано: (2012)

Poxviral Ankyrin Proteins
по: Michael H. Herbert, и др.
Опубликовано: (2015-02-01)

Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
по: Naif Khalaf Alharbi
Опубликовано: (2019-01-01)

Effective induction of high-titer antibodies by viral vector vaccines.
по: Draper, S, и др.
Опубликовано: (2008)

Methods of treating Poxviral Infections
по: Ramstedt, U, и др.
Опубликовано: (2011)

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
по: Toritse Orubu, и др.
Опубликовано: (2012-01-01)

Poxviral Strategies to Overcome Host Cell Apoptosis
по: Chathura D. Suraweera, и др.
Опубликовано: (2020-12-01)

Poxviral Targeting of Interferon Regulatory Factor Activation
по: Clara Lawler, и др.
Опубликовано: (2020-10-01)

Prime-boost vectored malaria vaccines: progress and prospects.
по: Hill, A, и др.
Опубликовано: (2010)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
по: Sheerin, D, и др.
Опубликовано: (2021)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
по: Dylan Sheerin, и др.
Опубликовано: (2021-10-01)

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
по: Goodman, A, и др.
Опубликовано: (2010)

Nodular Dermatitis: Emergence of Novel Poxviral Infection in Russia
по: S. V. Borisevich, и др.
Опубликовано: (2018-04-01)

Origin of the poxviral membrane: A 50-year-old riddle.
по: Bernard Moss
Опубликовано: (2018-06-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
по: Dicks, M, и др.
Опубликовано: (2011)

Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
по: Jarmila Knitlova, и др.
Опубликовано: (2014-01-01)

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1, (vol 78, pg 4610, 2010)
по: Goodman, A, и др.
Опубликовано: (2011)

Poxviral ANKR/F-box Proteins: Substrate Adapters for Ubiquitylation and More
по: Robert J. Ingham, и др.
Опубликовано: (2022-08-01)

T cell inactivation by poxviral B22 family proteins increases viral virulence.
по: Dina Alzhanova, и др.
Опубликовано: (2014-05-01)

Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome.
по: Cottingham, MG, и др.
Опубликовано: (2010)

Viral vectors as vaccine platforms: Deployment in sight
по: Rollier, C, и др.
Опубликовано: (2011)

Viral vectors as vaccine platforms: deployment in sight.
по: Rollier, C, и др.
Опубликовано: (2011)

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
по: Smith, C, и др.
Опубликовано: (2005)

Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
по: Skinner, M, и др.
Опубликовано: (2005)

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
по: Martin C. Langenmayer, и др.
Опубликовано: (2023-06-01)

Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
по: Mostafa Jarahian, и др.
Опубликовано: (2011-08-01)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
по: Biswas, S, и др.
Опубликовано: (2011)

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter
по: Alharbi, N, и др.
Опубликовано: (2015)

Viruses as vaccine vectors for infectious diseases and cancer.
по: Draper, S, и др.
Опубликовано: (2010)

Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.
по: Guzman, E, и др.
Опубликовано: (2012)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
по: Sarah Wilmschen, и др.
Опубликовано: (2019-09-01)

New vectored vaccines for malaria.
по: Hill, A, и др.
Опубликовано: (2008)

SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family
по: Shchelkunov Sergei N, и др.
Опубликовано: (2010-10-01)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
по: Ewer, K, и др.
Опубликовано: (2015)

Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.
по: Cottingham, MG, и др.
Опубликовано: (2006)

Discovery of a heparan sulfate binding domain in monkeypox virus H3 as an anti-poxviral drug target combining AI and MD simulations
по: Bin Zheng, и др.
Опубликовано: (2025-01-01)

Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
по: Biswas, S, и др.
Опубликовано: (2012)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
по: Cottingham, MG, и др.
Опубликовано: (2012)